Elan Corp PLC (ELN)

[docbanker]

You have to ask yourself why ELN was trying for NTB in the first place and if the EMEA de-emphasizing it is a good thing.

One thing that confuses me is that bulls in this name say that starting a PIII trial automatically means the PII results at the interim look showed a "strong" trend. If this were the case, (i) why are the PIII trials well over 10x the size per arm and (ii) why in WYE's conference call did WYE CHANGE their reasoning for starting the PIIIs from (something like) only going to start it if PII were really good TO we are starting PIII b/c of (something like) encouraging trend, our immunology platform is great and there is a need for more drugs in the space (doesnt this sound watered down to you?)